prednisone has been researched along with Leishmaniasis, Visceral in 10 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In Spain, however, a HIV-negative man with a history of chronic obstructive pulmonary disease and prednisone treatment was recently hospitalized because of hypotension and asthenia." | 3.73 | Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate. ( Garcia-Cordoba, F; Gonzalez Diaz, G; Ortuño, FJ; Segovia, M, 2005) |
| "A case of Hodgkin's disease associated from the start with visceral leishmaniasis in the absence of antitumoral treatment shows that leishmaniasis is a severe opportunistic infection in endemic areas and can be masked by the tumoral syndrome of an underlying pathology." | 2.38 | [Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties]. ( Blanc, AP; Jacquème, P; Magnan, A; Poirier, R; Redding, E; Sudan, N, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clemente, W | 1 |
| Vidal, E | 1 |
| Girão, E | 1 |
| Ramos, AS | 1 |
| Govedic, F | 1 |
| Merino, E | 1 |
| Muñoz, P | 1 |
| Sabé, N | 1 |
| Cervera, C | 1 |
| Cota, GF | 1 |
| Cordero, E | 1 |
| Mena, A | 1 |
| Montejo, M | 1 |
| López-Medrano, F | 1 |
| Aguado, JM | 1 |
| Fernandes, P | 1 |
| Valerio, M | 1 |
| Carratalá, J | 1 |
| Moreno, A | 1 |
| Oliveira, J | 1 |
| Mourão, PH | 1 |
| Torre-Cisneros, J | 1 |
| Barešić, M | 1 |
| Janka, GE | 1 |
| Gjadrov-Kuveždić, K | 1 |
| Zekan, Š | 1 |
| Anić, B | 1 |
| Maio, P | 1 |
| Leone, S | 1 |
| Volpe, S | 1 |
| dell'Aquila, G | 1 |
| Giglio, S | 1 |
| Magliocca, M | 1 |
| Nigro, FS | 1 |
| Pacifico, P | 1 |
| Acone, N | 1 |
| Moreno, D | 1 |
| Martínez, P | 1 |
| Berbegal, J | 1 |
| Femenia, M | 1 |
| Cosset, J | 1 |
| Amiel, JL | 1 |
| MEMIN, Y | 1 |
| PERNOD, J | 1 |
| LARRIBAUD, J | 1 |
| Garcia-Cordoba, F | 1 |
| Ortuño, FJ | 1 |
| Segovia, M | 1 |
| Gonzalez Diaz, G | 1 |
| Cortese, L | 1 |
| Pelagalli, A | 1 |
| Piantedosi, D | 1 |
| Mastellone, V | 1 |
| Di Loria, A | 1 |
| Lombardi, P | 1 |
| Ciaramella, P | 1 |
| Avallone, L | 1 |
| Punda-Polić, V | 1 |
| Bradarić, N | 1 |
| Marty, P | 1 |
| Lelièvre, A | 1 |
| Magnan, A | 1 |
| Jacquème, P | 1 |
| Sudan, N | 1 |
| Redding, E | 1 |
| Blanc, AP | 1 |
| Poirier, R | 1 |
2 reviews available for prednisone and Leishmaniasis, Visceral
| Article | Year |
|---|---|
[Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab: a case description and literature review].
Topics: Adalimumab; Aged; Animals; Animals, Domestic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humani | 2010 |
[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Bleomycin; Dacarbazine; | 1991 |
8 other studies available for prednisone and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Risk factors, clinical features and outcomes of visceral leishmaniasis in solid-organ transplant recipients: a retrospective multicenter case-control study.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antiprotozoal Agents; Case-Control Studies; Femal | 2015 |
Visceral leishmaniasis triggering (mimicking) macrophage activation syndrome in a patient with adult onset Still disease.
Topics: Adult; Bone Marrow; Cyclosporine; Diagnosis, Differential; Humans; Leishmaniasis, Visceral; Macropha | 2016 |
Visceral leishmaniasis in a patient with common variable immunodeficiency and evans syndrome: clinical remarks.
Topics: Amphotericin B; Anemia, Hemolytic, Autoimmune; Antiprotozoal Agents; Common Variable Immunodeficienc | 2009 |
[Kalaazar and cortancyl].
Topics: Humans; Leishmaniasis; Leishmaniasis, Visceral; Prednisone | 1958 |
[IMPORTANCE OF LYMPH NODE BIOPSY IN THE DIAGNOSIS OF KALA-AZAR IN THE ADULT].
Topics: Adult; Antimony; Biopsy; Blood Protein Disorders; Blood Protein Electrophoresis; Diagnosis; Humans; | 1963 |
Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate.
Topics: Antiprotozoal Agents; Bone Marrow; Bone Marrow Diseases; Fatal Outcome; Glucocorticoids; HIV Seroneg | 2005 |
The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Homeostasis; Leishmania infa | 2008 |
Serological response to Leishmania infantum in a patient treated with prednisone.
Topics: Animals; Antigens, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Blotting, Western; Ch | 1998 |